中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A negative allosteric modulator modulates GABA(B)-receptor signalling through GB2 subunits

文献类型:期刊论文

作者Sun, Bing2,3; Chen, Linhai1; Liu, Lei2,3; Xia, Zhixiong2,3; Pin, Jean-Philippe4; Nan, Fajun1; Liu, Jianfeng2,3
刊名BIOCHEMICAL JOURNAL
出版日期2016-03-15
卷号473页码:779-787
关键词cerebellar granular neurons GABA(B)-receptor heptahelical domain negative allosteric modulator
ISSN号0264-6021
DOI10.1042/BJ20150979
文献子类Article
英文摘要An gamma-aminobutyric acid type B (GABA(B))-receptor mediates slow and prolonged synaptic inhibition in the central nervous system, which represents an interesting target for the treatment of various diseases and disorders of the central nervous system. To date, only one activator of the GABA(B)-receptor, baclofen, is on the market for the treatment of spasticity. Inhibitors of the GABA(B)-receptor, such as antagonists, show anti-absence seizure activity and procognitive properties. In a search for allosteric compounds of the GABA(B)-receptor, although several positive allosteric modulators have been developed, it is only recently that the first negative allosteric modulator (NAM), CLH304a (also named Compound 14), has been reported. In the present study, we provide further information on the mechanism of action of CLH304a, and also show the possibility of designing more NAMs, such as CLH391 and CLH393, based on the structure of CLH304a. First we show that CLH304a inhibits native GABA(B)-receptor activity in cultured cerebellar granular neurons. We then show that CLH304a has inverse agonist properties and non-competitively inhibits the effect of agonists, indicating that it binds at a different site to GABA. The GABA(B)-receptor is a mandatory heterodimer made of GB1 subunits, in which agonists bind, and GB2 subunits, which activate G-proteins. By using various combinations made up of wild-type and/or mutated GB1 and GB2 subunits, we show that CLH304a acts on the heptahelical domain of GB2 subunits. These data revealed the possibility of designing innovative NAMs acting in the heptahelical domain of the GB2 subunits, offering novel possibilities for therapeutic intervention based on GABA(B)-receptor inhibition.
WOS关键词GABA-B RECEPTORS ; N,N'-DICYCLOPENTYL-2-METHYLSULFANYL-5-NITRO-PYRIMIDINE-4,6-DIAMINE GS39783 ; HEPTAHELICAL DOMAIN ; ACID(B) RECEPTORS ; C-TERMINI ; GAMMA ; PHARMACOLOGY ; ANTAGONIST ; ACTIVATION ; GLUTAMATE
资助项目National Natural Science Foundation of China[NSFC] ; Ministry of Science and Technology[2012CB518000] ; Program of Introducing Talents of Discipline to the Universities of the Ministry of Education[B08029] ; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)[IRT13016] ; Natural Science Foundation of Hubei province[2014CFA010] ; Merieux Research Grants Program of Institut-Merieux[00000000]
WOS研究方向Biochemistry & Molecular Biology
语种英语
WOS记录号WOS:000377208100011
出版者PORTLAND PRESS LTD
源URL[http://119.78.100.183/handle/2S10ELR8/276100]  
专题国家新药筛选中心
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Nan, Fajun; Liu, Jianfeng
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Natl Ctr Drug Screening, Shanghai 200031, Peoples R China;
2.Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Cellular Signalling Lab, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China;
3.Huazhong Univ Sci & Technol, Collaborat Innovat Ctr Brain Sci, Wuhan 430074, Peoples R China;
4.Univ Montpellier 1&2, CNRS, MMR 5203, Inst Genom Fonct, F-34094 Montpellier 5, France
推荐引用方式
GB/T 7714
Sun, Bing,Chen, Linhai,Liu, Lei,et al. A negative allosteric modulator modulates GABA(B)-receptor signalling through GB2 subunits[J]. BIOCHEMICAL JOURNAL,2016,473:779-787.
APA Sun, Bing.,Chen, Linhai.,Liu, Lei.,Xia, Zhixiong.,Pin, Jean-Philippe.,...&Liu, Jianfeng.(2016).A negative allosteric modulator modulates GABA(B)-receptor signalling through GB2 subunits.BIOCHEMICAL JOURNAL,473,779-787.
MLA Sun, Bing,et al."A negative allosteric modulator modulates GABA(B)-receptor signalling through GB2 subunits".BIOCHEMICAL JOURNAL 473(2016):779-787.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。